Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 44NIH 10NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma 32Lymphoma, Follicular 13Lymphoma, Large B-Cell, Diffuse 12Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Mantle-Cell 8Burkitt Lymphoma 8Lymphoma, Non-Hodgkin 4Waldenstrom Macroglobulinemia 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Leukemia 3Lymphoma, B-Cell, Marginal Zone 2Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Myelodysplastic Syndromes 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Immunoblastic Lymphadenopathy 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1

Interventions

Radiotherapy 4Vincristine 3Rituximab 3Prednisone 3Etoposide 3Cyclophosphamide 3Methotrexate 2Immunohistochemistry 2Doxorubicin 2Cytarabine 2Cisplatin 2sargramostim 1pegfilgrastim 1merphos 1liposomal amphotericin B 1ixabepilone 1ibritumomab tiuxetan 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1VAP-cyclo protocol 1Tazobactam 1Radioimmunotherapy 1Polymerase Chain Reaction 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Photopheresis 1Peripheral Blood Stem Cell Transplantation 1Pentostatin 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large-Cell, Immunoblastic × Rituximab × Clear all
NCT00004031 2021-02-02

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

SWOG Cancer Research Network

Phase 3 Completed
397 enrolled 14 charts
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00389818 2018-06-06

Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Completed
43 enrolled 7 charts
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡